Cannapharmarx (CPMD) Price & Analysis

Q: What is Cannapharmarx Inc’s market cap?

Cannapharmarx Inc’s market cap is $3.25M.

Q: When is Cannapharmarx Inc’s upcoming earnings report date?

Cannapharmarx Inc’s upcoming earnings report date is May 19, 2026 which is in 77 days.

Q: How were Cannapharmarx Inc’s earnings last quarter?

Cannapharmarx Inc released its earnings results on May 20, 2025. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.

Q: Is Cannapharmarx Inc overvalued?

According to Wall Street analysts Cannapharmarx Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Cannapharmarx Inc pay dividends?

Cannapharmarx Inc does not currently pay dividends.

Q: What is Cannapharmarx Inc’s EPS estimate?

Cannapharmarx Inc’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Cannapharmarx Inc have?

Cannapharmarx Inc has 662,501,400 shares outstanding.

Q: What happened to Cannapharmarx Inc’s price movement after its last earnings report?

Cannapharmarx Inc reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Cannapharmarx Inc?

Currently, no hedge funds are holding shares in CPMD

Q: What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Compare

59 Followers

CPMD Stock Chart & Stats

$0.01

<$0.01(11.76%)

At close: Jan 08 4:00 PM EST

$0.01

<$0.01(11.76%)

Day’s Range― - ―

52-Week Range― - ―

Previous CloseN/A

Volume41.77K

Average Volume (3M)N/A

Market Cap

$3.25M

Enterprise Value$27.77M

Total Cash (Recent Filing)$927.00

Total Debt (Recent Filing)$24.99M

Price to Earnings (P/E)―

Beta-0.34

Next Earnings

May 19, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding662,501,400

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)-0.26

Price to Sales (P/S)6.18

P/FCF Ratio-2.98

Enterprise Value/Market Cap8.56

Enterprise Value/Revenue16.28

Enterprise Value/Gross Profit-8.53

Enterprise Value/Ebitda-8.59

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSubstantial revenue growth indicates strong demand and potential market expansion, suggesting the company is capturing a larger share of the cannabis market.

Leadership ChangeThe appointment of a new CEO with extensive industry experience could drive strategic improvements and operational efficiency, enhancing long-term business prospects.

Board ExpertiseThe addition of experienced board members could strengthen strategic decision-making and expand industry networks, supporting sustainable growth.

Bears Say

Negative EquityNegative equity indicates financial distress, as liabilities exceed assets, posing a risk to long-term viability and limiting financial flexibility.

Cash Flow IssuesLack of positive cash flow suggests liquidity challenges and inefficient cash management, which could hinder operational sustainability and growth.

High LeverageHigh leverage increases financial risk, potentially leading to difficulties in meeting obligations and limiting the ability to invest in growth opportunities.

Cannapharmarx News

CannaPharmaRX Has Cease Trade Order Revoked, Plans Restructuring

Cannapharmarx ( ($CPMD) ) has provided an update. On December 12, 2025, CannaPharmaRX announced that the British Columbia...

3M ago

CPMD

CannaPharmaRX Addresses Debt with New Agreements

Cannapharmarx ( ($CPMD) ) has issued an update. CannaPharmaRX, Inc. has entered into letter agreements with payment schedules...

5M ago

CPMD

CannaPharmaRX Expands Global Cannabis Exports and Projects Strong Q3 Revenue

Cannapharmarx ( ($CPMD) ) has issued an announcement. CannaPharmaRX has announced strategic developments to enhance its international presence...

7M ago

CPMD

CannaPharmaRX Expands European Market Reach with German Shipment

Cannapharmarx ( ($CPMD) ) has issued an announcement. CannaPharmaRX has successfully completed shipments of cannabis to Israel and...

10M ago

CPMD

Cannapharmarx Appoints Constantine Nkafu as Interim CEO

Cannapharmarx ( ($CPMD) ) just unveiled an update. Cannapharmarx has appointed Constantine Nkafu as the interim CEO, who...

11M ago

CPMD

CannaPharmaRX Expands Cannabis Production and Profitability

Cannapharmarx (CPMD) has released an update. CannaPharmaRX is making significant strides in cannabis production with its advanced facility...

1y ago

CPMD

CannaPharmaRx Achieves First Harvest Milestone

Cannapharmarx (CPMD) has released an update. CannaPharmaRx, an emerging power in the cannabis production industry, has successfully completed...

2y ago

CPMD

CannaPharmaRx Targets High Growth in 2023

Cannapharmarx (CPMD) has released an update. CannaPharmaRx is poised for robust growth in 2023 following a foundational year...

2y ago

CPMD

CannaPharmaRx Expands to Latin America with ICAN

Cannapharmarx (CPMD) has released an update. CannaPharmaRx, an emerging leader in cannabis production, has entered a supply agreement...

2y ago

CPMD

CannaPharmaRx Schedules Investor Update Call

Cannapharmarx (CPMD) has released an update. CannaPharmaRx, an emerging leader in advanced cannabis production, has announced an investor...

2y ago

CPMD

CPMD FAQ

What was Cannapharmarx Inc’s price range in the past 12 months?

Currently, no data Available

What is Cannapharmarx Inc’s market cap?

Cannapharmarx Inc’s market cap is $3.25M.

When is Cannapharmarx Inc’s upcoming earnings report date?

Cannapharmarx Inc’s upcoming earnings report date is May 19, 2026 which is in 77 days.

How were Cannapharmarx Inc’s earnings last quarter?

Cannapharmarx Inc released its earnings results on May 20, 2025. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.

Is Cannapharmarx Inc overvalued?

According to Wall Street analysts Cannapharmarx Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cannapharmarx Inc pay dividends?

Cannapharmarx Inc does not currently pay dividends.

What is Cannapharmarx Inc’s EPS estimate?

Cannapharmarx Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cannapharmarx Inc have?

Cannapharmarx Inc has 662,501,400 shares outstanding.

What happened to Cannapharmarx Inc’s price movement after its last earnings report?

Cannapharmarx Inc reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Cannapharmarx Inc?

Currently, no hedge funds are holding shares in CPMD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cannapharmarx Inc

CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.